| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
75,467 |
56,437 |
$5.13M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
40,889 |
34,702 |
$2.16M |
| 99401 |
|
65,583 |
51,652 |
$1.92M |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
4,794 |
4,596 |
$501K |
| 92557 |
|
14,271 |
13,960 |
$480K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
3,848 |
3,792 |
$374K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
4,070 |
4,012 |
$367K |
| 99215 |
Prolong outpt/office vis |
3,638 |
3,141 |
$317K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
11,741 |
11,348 |
$222K |
| 99385 |
|
1,988 |
1,937 |
$190K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
5,942 |
5,403 |
$173K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
2,340 |
2,281 |
$168K |
| 99441 |
|
3,808 |
3,323 |
$162K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
1,924 |
1,911 |
$159K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
4,962 |
4,030 |
$153K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
10,164 |
7,320 |
$134K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
1,276 |
1,247 |
$113K |
| 99442 |
|
1,550 |
1,399 |
$102K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
2,089 |
2,040 |
$82K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
6,117 |
5,575 |
$76K |
| 36415 |
Collection of venous blood by venipuncture |
24,265 |
22,495 |
$71K |
| 93880 |
|
540 |
511 |
$62K |
| 90686 |
|
5,734 |
5,321 |
$52K |
| 99205 |
Prolong outpt/office vis |
406 |
379 |
$50K |
| 99386 |
|
440 |
428 |
$49K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
3,657 |
2,990 |
$48K |
| 93923 |
|
531 |
510 |
$46K |
| 99402 |
|
984 |
700 |
$43K |
| Q0091 |
Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory |
1,127 |
1,089 |
$42K |
| 93000 |
|
2,999 |
2,904 |
$41K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
496 |
492 |
$39K |
| 93925 |
|
276 |
260 |
$36K |
| 90674 |
|
1,814 |
1,741 |
$36K |
| 81025 |
|
4,794 |
4,443 |
$34K |
| G0101 |
Cervical or vaginal cancer screening; pelvic and clinical breast examination |
989 |
955 |
$33K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
393 |
372 |
$31K |
| 0012A |
|
515 |
475 |
$20K |
| 99000 |
|
11,824 |
10,064 |
$19K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,617 |
1,512 |
$18K |
| 0011A |
|
537 |
477 |
$18K |
| 99397 |
|
185 |
184 |
$17K |
| 99173 |
|
10,937 |
10,158 |
$15K |
| 0001A |
|
212 |
204 |
$12K |
| 0002A |
|
191 |
182 |
$12K |
| 94060 |
|
271 |
251 |
$12K |
| 90694 |
|
548 |
517 |
$11K |
| 93930 |
|
114 |
107 |
$11K |
| 0013A |
|
168 |
159 |
$10K |
| 90656 |
|
426 |
358 |
$9K |
| 81002 |
|
2,998 |
2,815 |
$9K |
| 0003A |
|
137 |
127 |
$8K |
| 99443 |
|
84 |
78 |
$8K |
| 94760 |
|
7,737 |
5,762 |
$7K |
| 86328 |
|
583 |
383 |
$7K |
| 94664 |
|
570 |
502 |
$7K |
| 97802 |
|
1,825 |
1,596 |
$6K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
99 |
94 |
$5K |
| 90653 |
|
122 |
121 |
$5K |
| 96160 |
|
1,931 |
1,858 |
$5K |
| 93042 |
|
620 |
608 |
$4K |
| 87210 |
|
812 |
769 |
$4K |
| 93970 |
|
26 |
26 |
$4K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
257 |
213 |
$4K |
| 76536 |
|
56 |
55 |
$3K |
| 83014 |
|
488 |
467 |
$3K |
| 0072A |
|
33 |
33 |
$3K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
1,866 |
1,607 |
$3K |
| 90662 |
|
235 |
202 |
$3K |
| 99383 |
|
26 |
26 |
$2K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
27 |
26 |
$2K |
| G0439 |
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit |
318 |
295 |
$2K |
| 0071A |
|
24 |
24 |
$2K |
| 90651 |
|
259 |
230 |
$2K |
| 20605 |
|
44 |
44 |
$2K |
| 90670 |
|
43 |
37 |
$2K |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
1,311 |
948 |
$2K |
| 92250 |
|
33 |
32 |
$1K |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
298 |
260 |
$1K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
13 |
12 |
$960.36 |
| 90715 |
|
91 |
82 |
$659.68 |
| 99349 |
|
19 |
13 |
$613.98 |
| 82962 |
|
203 |
175 |
$527.85 |
| 0064A |
|
39 |
32 |
$500.00 |
| 90480 |
|
15 |
15 |
$450.20 |
| 0134A |
|
16 |
14 |
$332.00 |
| 86580 |
|
29 |
28 |
$275.19 |
| 99348 |
|
31 |
19 |
$253.55 |
| G0444 |
Annual depression screening, 5 to 15 minutes |
111 |
91 |
$161.76 |
| G0008 |
Administration of influenza virus vaccine |
340 |
318 |
$102.56 |
| J3490 |
Unclassified drugs |
474 |
225 |
$94.06 |
| G0270 |
Medical nutrition therapy; reassessment and subsequent intervention(s) following second referral in same year for change in diagnosis, medical condition or treatment regimen (including additional hours needed for renal disease), individual, face to face with the patient, each 15 minutes |
73 |
52 |
$93.59 |
| J7644 |
Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram |
520 |
438 |
$93.36 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
485 |
410 |
$52.06 |
| 3008F |
|
5,323 |
4,216 |
$41.48 |
| 99070 |
|
1,634 |
1,327 |
$30.69 |
| 90713 |
|
203 |
179 |
$14.24 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
450 |
350 |
$6.96 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
147 |
141 |
$5.24 |
| J8499 |
Prescription drug, oral, non chemotherapeutic, nos |
60 |
51 |
$3.00 |
| 3078F |
|
1,585 |
1,264 |
$0.00 |
| 1160F |
|
393 |
340 |
$0.00 |
| 1159F |
|
354 |
300 |
$0.00 |
| 90700 |
|
298 |
272 |
$0.00 |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
1,098 |
971 |
$0.00 |
| 91300 |
|
154 |
124 |
$0.00 |
| 3077F |
|
173 |
134 |
$0.00 |
| 90687 |
|
30 |
30 |
$0.00 |
| 90649 |
|
21 |
19 |
$0.00 |
| 90707 |
|
31 |
27 |
$0.00 |
| 90734 |
|
41 |
38 |
$0.00 |
| 90648 |
|
14 |
13 |
$0.00 |
| 97803 |
|
18 |
17 |
$0.00 |
| 90633 |
|
13 |
13 |
$0.00 |
| 3074F |
|
2,018 |
1,633 |
$0.00 |
| 1125F |
|
61 |
55 |
$0.00 |
| 91301 |
|
505 |
364 |
$0.00 |
| 3075F |
|
184 |
165 |
$0.00 |
| 3079F |
|
651 |
532 |
$0.00 |
| 1170F |
|
391 |
338 |
$0.00 |
| 3080F |
|
223 |
177 |
$0.00 |
| 1126F |
|
88 |
78 |
$0.00 |
| 90716 |
|
62 |
52 |
$0.00 |
| 3044F |
|
14 |
12 |
$0.00 |
| 99406 |
|
22 |
13 |
$0.00 |